Clorox reports results on Monday 2 November, after the market closes. Revenue over the twelve months to Q3 2026 was $6.8 billion, down 3.7% on the year before. The report will test whether the recent pick-up in growth continues.
Source: reported quarterly EPS and aggregated third-party estimates. Historical surprises are context, not a forecast.
View chart data
| Period | Reported EPS | Analysts' estimate |
|---|---|---|
| Sep '25 | $0.85 | $0.78 |
| Dec '25 | $1.39 | $1.43 |
| Mar '26 | $1.64 | $1.54 |
| Jun '26 | $1.66 | $1.65 |
What analysts expect from Clorox
The analysts' average EPS estimate for the quarter is $1.07, in a range from $0.81 to $1.20. The average revenue estimate for the quarter is $1.9 billion. For the full year, the analysts' average EPS estimate is $5.70, up 3.1% on last year based on 17 analysts. That estimate has fallen 5.2% over the past 90 days. The split in recommendations is 1 positive, 13 neutral and 4 negative.
Company guidance
In its latest earnings release, management set fiscal year 2027 Adjusted EPS guidance at $5.70 to $6.00. Diluted EPS guidance for the same period is $5.41 to $5.71.
Earnings surprise model
Our model estimates EPS could land above the analysts' average estimate by 1.8%. The estimated chance of an EPS beat is 62.5%, based on the last 4 quarters. The model shrinks the median recent surprise toward zero and uses a neutral prior for beat frequency; this small sample is a reference estimate, not company guidance.
Clorox's record against estimates
The company reported EPS above the analysts' average estimate in 3 of the last 4 quarters. Last quarter, EPS of $1.66 compared with an estimate of $1.65, above it by 0.9%.
The decline in sales is easing
Revenue is still declining, but the rate of decline is narrowing. That growth rate was up 2.0 percentage points on the rate a quarter earlier. The trailing gross margin was 43.8% and the trailing net margin was 11.2%. Net income over the twelve months was $756.0 million, up 8.9% on the year before, even as revenue fell.
Cash flow moves in the opposite direction. Operating cash flow over the twelve months was $576.0 million, down 43.9% on the year before. Capital spending was $196.0 million, or 2.9% of revenue, so the free cash flow decline tracks the operating side. Free cash flow was $380.0 million, down 52.6% on the year before. That puts the free-cash-flow margin at 5.6% of revenue, down 5.8 percentage points from a year earlier. The average diluted share count fell 1.7% over the year.
Against its own history, today's free-cash-flow margin of 5.6% is below every past quarterly reading, which have ranged from 6.8% to 19.5%. The twelve-month revenue growth rate of −3.7% is higher than only 9% of past readings in a range from −9.3% to 22.7%.
Questions this report will answer
The report will answer whether the pick-up in revenue growth continues, whether results land above or below the analysts' expectations set out above, and whether margins hold at the trailing levels above.
The value hinges on margins more than growth
In our model, growth 5 percentage points lower would lower the value by 42.1%, and growth 5 percentage points higher would raise it by 55.4%. A free-cash-flow margin 1 percentage point lower would lower it by 24.8%.
